373 related articles for article (PubMed ID: 19383918)
1. Antitumor activity of gammadelta T cells reactive against cytomegalovirus-infected cells in a mouse xenograft tumor model.
Devaud C; Bilhere E; Loizon S; Pitard V; Behr C; Moreau JF; Dechanet-Merville J; Capone M
Cancer Res; 2009 May; 69(9):3971-8. PubMed ID: 19383918
[TBL] [Abstract][Full Text] [Related]
2. Shared reactivity of V{delta}2(neg) {gamma}{delta} T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells.
Halary F; Pitard V; Dlubek D; Krzysiek R; de la Salle H; Merville P; Dromer C; Emilie D; Moreau JF; Déchanet-Merville J
J Exp Med; 2005 May; 201(10):1567-78. PubMed ID: 15897274
[TBL] [Abstract][Full Text] [Related]
3. Anti-metastatic potential of human Vδ1(+) γδ T cells in an orthotopic mouse xenograft model of colon carcinoma.
Devaud C; Rousseau B; Netzer S; Pitard V; Paroissin C; Khairallah C; Costet P; Moreau JF; Couillaud F; Dechanet-Merville J; Capone M
Cancer Immunol Immunother; 2013 Jul; 62(7):1199-210. PubMed ID: 23619975
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity and some immunological properties of gammadelta T-cells from patients with gastrointestinal carcinomas.
Murayama M; Tanaka Y; Yagi J; Uchiyama T; Ogawa K
Anticancer Res; 2008; 28(5B):2921-31. PubMed ID: 19031935
[TBL] [Abstract][Full Text] [Related]
5. Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy.
Schilbach K; Frommer K; Meier S; Handgretinger R; Eyrich M
J Immunother; 2008; 31(9):896-905. PubMed ID: 18832998
[TBL] [Abstract][Full Text] [Related]
6. Adoptive immunotherapy of cancer using ex vivo expanded human gammadelta T cells: A new approach.
Dokouhaki P; Han M; Joe B; Li M; Johnston MR; Tsao MS; Zhang L
Cancer Lett; 2010 Nov; 297(1):126-36. PubMed ID: 20537791
[TBL] [Abstract][Full Text] [Related]
7. Expansion of effector memory Vδ2
Huang Y; Jiang C; Zhu J; Lin L; Mao M; Yin T; Cai G
Front Immunol; 2024; 15():1397483. PubMed ID: 38915409
[TBL] [Abstract][Full Text] [Related]
8. Intravesical administration of gammadelta T cells successfully prevents the growth of bladder cancer in the murine model.
Yuasa T; Sato K; Ashihara E; Takeuchi M; Maita S; Tsuchiya N; Habuchi T; Maekawa T; Kimura S
Cancer Immunol Immunother; 2009 Apr; 58(4):493-502. PubMed ID: 18682944
[TBL] [Abstract][Full Text] [Related]
9. Innate anti-breast cancer immunity of apoptosis-resistant human gammadelta-T cells.
Guo BL; Liu Z; Aldrich WA; Lopez RD
Breast Cancer Res Treat; 2005 Sep; 93(2):169-75. PubMed ID: 16187237
[TBL] [Abstract][Full Text] [Related]
10. Direct and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney Transplantation.
Couzi L; Pitard V; Moreau JF; Merville P; Déchanet-Merville J
Front Immunol; 2015; 6():3. PubMed ID: 25653652
[TBL] [Abstract][Full Text] [Related]
11. Surveillance of γδ T Cells Predicts Cytomegalovirus Infection Resolution in Kidney Transplants.
Kaminski H; Garrigue I; Couzi L; Taton B; Bachelet T; Moreau JF; Déchanet-Merville J; Thiébaut R; Merville P
J Am Soc Nephrol; 2016 Feb; 27(2):637-45. PubMed ID: 26054538
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus drives Vδ2neg γδ T cell inflation in many healthy virus carriers with increasing age.
Alejenef A; Pachnio A; Halawi M; Christmas SE; Moss PA; Khan N
Clin Exp Immunol; 2014 Jun; 176(3):418-28. PubMed ID: 24547915
[TBL] [Abstract][Full Text] [Related]
13. Perspectives of gammadelta T cells in tumor immunology.
Kabelitz D; Wesch D; He W
Cancer Res; 2007 Jan; 67(1):5-8. PubMed ID: 17210676
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus infection in transplant recipients resolves when circulating gammadelta T lymphocytes expand, suggesting a protective antiviral role.
Lafarge X; Merville P; Cazin MC; Bergé F; Potaux L; Moreau JF; Déchanet-Merville J
J Infect Dis; 2001 Sep; 184(5):533-41. PubMed ID: 11494158
[TBL] [Abstract][Full Text] [Related]
15. Targeting solid tumors via T cell receptor complementarity-determining region 3delta in an engineered antibody.
Wang Z; Zhang T; Hu H; Zhang H; Yang Z; Cui L; He W
Cancer Lett; 2008 Dec; 272(2):242-52. PubMed ID: 18782650
[TBL] [Abstract][Full Text] [Related]
16. Human gammadelta T cells as mediators of chimaeric-receptor redirected anti-tumour immunity.
Rischer M; Pscherer S; Duwe S; Vormoor J; Jürgens H; Rossig C
Br J Haematol; 2004 Aug; 126(4):583-92. PubMed ID: 15287953
[TBL] [Abstract][Full Text] [Related]
17. Dual-specific T cells combine proliferation and antitumor activity.
Kershaw MH; Westwood JA; Hwu P
Nat Biotechnol; 2002 Dec; 20(12):1221-7. PubMed ID: 12415288
[TBL] [Abstract][Full Text] [Related]
18. Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates.
Cesson V; Stirnemann K; Robert B; Luescher I; Filleron T; Corradin G; Mach JP; Donda A
Clin Cancer Res; 2006 Dec; 12(24):7422-30. PubMed ID: 17189415
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor expression and function in subsets of human gammadelta T lymphocytes.
Pietschmann K; Beetz S; Welte S; Martens I; Gruen J; Oberg HH; Wesch D; Kabelitz D
Scand J Immunol; 2009 Sep; 70(3):245-55. PubMed ID: 19703014
[TBL] [Abstract][Full Text] [Related]
20. Adoptive immunotherapy of lung cancer with immobilized anti-TCRgammadelta antibody-expanded human gammadelta T-cells in peripheral blood.
Kang N; Zhou J; Zhang T; Wang L; Lu F; Cui Y; Cui L; He W
Cancer Biol Ther; 2009 Aug; 8(16):1540-9. PubMed ID: 19471115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
